Tschudin, a Swiss citizen who speaks six languages, joined Novartis in 2017 after previously working at Celgene. She becomes president of Novartis Pharmaceuticals immediately.
(Reporting by John Miller, editing by John Revill)
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
108.2 USD | +0.10% | -1.97% | +68.89% |
ZURICH (Reuters) - Swiss pharmaceuticals giant Novartis named Marie-France Tschudin head of its main drugs business after its previous manager, Paul Hudson, was poised to take the CEO position at French drugmaker Sanofi.
Tschudin, a Swiss citizen who speaks six languages, joined Novartis in 2017 after previously working at Celgene. She becomes president of Novartis Pharmaceuticals immediately.
(Reporting by John Miller, editing by John Revill)
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
368.1 USD | -1.77% | -1.82% | 103B | ||
113.6 CHF | -1.00% | +1.34% | 36.87B | ||
92.73 CHF | -0.47% | +1.08% | 210B | ||
90.11 EUR | +0.39% | +0.66% | 122B | ||